California § 111793.5. 111793.5. (Added by Stats. 2005, Ch. 729, Sec. 2.)

California Statutes

§ 111793.5. — 111793.5. (Added by Stats. 2005, Ch. 729, Sec. 2.)

California § 111793.5.

JurisdictionCalifornia

Code HSCHealth and Safety Code - HSC

Div. 104.DIVISION 104. ENVIRONMENTAL HEALTH

Part 5.PART 5. SHERMAN FOOD, DRUG, AND COSMETIC LAWS

Ch. 7.CHAPTER 7. Cosmetics

Art. 3.5.ARTICLE 3.5. Chronic Health Effects of Cosmetics

This text of California § 111793.5. (111793.5. (Added by Stats. 2005, Ch. 729, Sec. 2.)) is published on Counsel Stack Legal Research, covering California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Cal. Health and Safety Code - HSC Code § 111793.5. (2026).

Text

(a)The Legislature finds and declares the following:

(1)The Cosmetic Ingredient Review (CIR) panel is a nongovernmental body established and funded by the cosmetics industry to review the safety of cosmetic ingredients.

(2)According to a 2004 analysis of the 2003 CIR Compendium by the Environmental Working Group, 54 cosmetic products violate the CIR’s own safe use recommendations to manufacturers by containing an ingredient that the CIR has found is not safe for the specific use indicated on the product’s label.

(3)Federal regulations (21 C.F.R. 740.10) require every ingredient in a cosmetic product and every finished cosmetic product to be adequately substantiated for safety prior to marketing, and state that any ingredient or product whose safety has not been adequately substan

Free access — add to your briefcase to read the full text and ask questions with AI

(a)
The Legislature finds and declares the following:
(1)
The Cosmetic Ingredient Review (CIR) panel is a nongovernmental body established and funded by the cosmetics industry to review the safety of cosmetic ingredients.
(2)
According to a 2004 analysis of the 2003 CIR Compendium by the Environmental Working Group, 54 cosmetic products violate the CIR’s own safe use recommendations to manufacturers by
containing an ingredient that the CIR has found is not safe for the specific use indicated on the product’s label.
(3)
Federal regulations (21 C.F.R. 740.10) require every ingredient in a cosmetic product and every finished cosmetic product to be adequately substantiated for safety prior to marketing, and state that any ingredient or product whose safety has not been adequately substantiated prior to marketing is misbranded unless it displays a warning statement declaring, “The safety of this product has not been determined.”
(b)
The division may, as early as feasible within existing resources, determine whether the products identified in paragraph (2) of subdivision (a) have been adequately substantiated for safety pursuant to Section 740.10 of Title 21 of the Code of Federal Regulations. For any product adequately substantiated for safety, the division shall determine if the
product contains any ingredient that the CIR has found is not safe for the specific use indicated on the product’s label.
(c)
If the division finds that a product has been adequately substantiated for safety despite containing an ingredient that the CIR has found is not safe for the specific use indicated on the product’s label, the division shall refer its findings to the Attorney General and the federal Food and Drug Administration for possible enforcement action pursuant to this part and the federal Food, Drug and Cosmetic Act (21 U.S.C. Sec. 301 et seq.).